KK

Kavita Kumari

Active Director Director DIN 08625276
DIN 08625276 First appointment Nov 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2019
Shareholding value •••• Premium profile

About Kavita Kumari

Data last updated:

Kavita Kumari is a Director at Manova Pharma Private Limited (since 2019). The company operates in Healthcare. Manova Pharma Private Limited reported revenue of ₹8.8 Lakh (FY 2022).

DIN 08625276
Primary Designation Director
Industry Healthcare
First Appointment 29 Nov 2019
Oldest Company Age 6 yrs
Largest company Manova Pharma Private Limited · ₹8.8 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Manova Pharma Private Limited U85100DL2019PTC358176
Director29 Nov 20192019₹8.8 Lakh (FY 2022)Active

Board colleagues of Kavita Kumari

NameDINCompanyDesignation
Kailash Singh08625277Manova Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Manova Pharma Private Limited
Premium access

Shareholding and investment profile for Kavita Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kavita Kumari

Kavita Kumari currently holds 1 directorship: Manova Pharma Private Limited (Director, since 29 Nov 2019, revenue ₹8.8 Lakh (FY 2022)).

Kavita Kumari was first appointed on 29 Nov 2019 as Director at Manova Pharma Private Limited.

The current boards of Kavita Kumari's companies include Kailash Singh (Manova Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available